Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naïve and –experienced patients

BACKGROUND: Telaprevir (TVR) has been approved for response-guided-therapy (RGT) of chronic hepatitis C (HCV) genotype-1-infection in treatment-naïve and –experienced patients. In RGT-regimens patients that did not achieve extended rapid-virological-response (eRVR) within the first 4–12 weeks underg...

Descripción completa

Detalles Bibliográficos
Autores principales: Goralczyk, Armin D, Cameron, Silke, Amanzada, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852825/
https://www.ncbi.nlm.nih.gov/pubmed/24118976
http://dx.doi.org/10.1186/1471-230X-13-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852825/
https://www.ncbi.nlm.nih.gov/pubmed/24118976
http://dx.doi.org/10.1186/1471-230X-13-148

Ejemplares similares